Evaluation of Computer-assisted, Non-cathartic CT Colonography (ncCTC)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01200303 |
Recruitment Status :
Completed
First Posted : September 13, 2010
Last Update Posted : August 5, 2015
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Colonic Polyps | Procedure: non-cathartic CTC | Phase 2 Phase 3 |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 605 participants |
Allocation: | N/A |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Diagnostic |
Official Title: | Prospective Evaluation of Computer-Assisted, Non-Cathartic CT Colonography for Detection of Adenomatous Colonic Polyps in a Screening Cohort |
Study Start Date : | June 2005 |
Actual Primary Completion Date : | October 2010 |
Actual Study Completion Date : | January 2011 |

Arm | Intervention/treatment |
---|---|
Active Comparator: non-cathartic CTC and OC
This is a single arm, open label, prospective test comparison of non-cathartic, CAD-assisted CTC to segmentally unblinded optical colonoscopy (OC). All study subjects receive both tests, starting with CTC, followed by OC within 5 weeks. CTC results are recorded and revealed to endoscopist on a segment-by-segment basis after initial (blinded) OC evaluation; endoscopist can double check / confirm lesion presence after unblinding and this second read serves as reference standard.
|
Procedure: non-cathartic CTC
non-cathartic, CAD-assisted CT Colonography
Other Name: tagging of non-cathartic CTC employs iohexol (Omnipaque 300) |
- Performance for detection of adenomatous colonic polyps > 6mm [ Time Frame: on per subject basis, metric will be assessed at unblinding OC (w/i 5 weeks enrollment); for cohort, summary statistics will be generated at study completion ]this is a prospective test comparison of non-cathartic, CAD-assisted CT Colonography to segmentally unblinded optical colonoscopy (OC), latter serving with pathology specimens as reference standard for presence of polyps.
- Patient comfort associated with non-cathartic exam preparation [ Time Frame: on per subject basis, outcome will be assessed at 5 weeks post enrollment (following OC); for cohort, summary statistics will be generated at study completion ]as part of the prospective test comparison, we are generating summary statistics of self-reported patient comfort assessments with the test (non-cathartic) exam preparation versus standard, cathartic preparation.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 50 Years to 80 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- age 50-80, eligible for colon screening
Exclusion Criteria:
- prior anatomic colon screening exam (optical colonoscopy, sigmoidoscopy, barium enema, CT Colonography) within last 5 years
- personal history of inflammatory bowel disease, polyposis syndrome, colo-rectal cancer, colon surgery
- documented passage of blood per rectum within last 12 months

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01200303
United States, California | |
UCSF-VA Medical Center | |
San Francisco, California, United States, 94121 | |
United States, Massachusetts | |
Massachusetts General Hospital | |
Boston, Massachusetts, United States, 02114 | |
Brigham and Women's Hospital | |
Boston, Massachusetts, United States, 02115 |
Principal Investigator: | Michael Zalis, MD | Massachusetts General Hospital |
Responsible Party: | Michael Zalis MD, Principal Investigator, Massachusetts General Hospital |
ClinicalTrials.gov Identifier: | NCT01200303 |
Other Study ID Numbers: |
GEH-03-OPQ-001 ACS 116256-RSG-08-221-01-CCE ( Other Grant/Funding Number: American Cancer Society ) |
First Posted: | September 13, 2010 Key Record Dates |
Last Update Posted: | August 5, 2015 |
Last Verified: | August 2015 |
colon cancer adenomatous colonic polyps colon screening |
CT Colonography (Virtual Colonoscopy) Computer Aided Detection Electronic Cleansing |
Polyps Colonic Polyps Pathological Conditions, Anatomical Intestinal Polyps |